TGFB1 and COVID-19: Assessment of airspace levels of TGF-β or airway immune cell TGF-β expression during COVID-19 ARDS have been limited to a few reports based on understandable desire to limit aerosolization of sputum from COVID-19 patients to research or clinical personnel.